in China they said they had been misinterpreted and Nicolás Kreplak spoke of “disinformation”

The director of the Center for Disease Control and Prevention of China, Gao Fu, assured on Monday that they misinterpreted his words on the “low efficacy” of vaccines in your country. His remarks, which took place at a press conference on Saturday, have been “taken out of context”, he assured.

At a press conference in Chengdu city on Saturday, the official said Chinese drugs “do not have very high levels of protection.” The information was picked up on Sunday by international news agencies such as EFE and AP and reproduced by the country’s news portals, including Clarín.

The refusal came just this Monday. “After discussing the different vaccination strategies, I raised the issue of the vaccine protection rate and expressed my thoughts on the fact that we can optimize our procurement process“Fu told the Chinese portal Guancha.com.

Immediately, Chinese state media rushed to defend local COVID-19 vaccines, to help Fu and clarify the situation, in the middle a wave of public skepticism towards vaccination.

Among Chinese vaccines, Argentina is already using Sinopharm and has contractually committed millions of additional doses. For this reason, Gao Fu’s statements gained prominence in the country and various media reached the pages.

But the Argentinian authorities, beyond the information coming from China and that this Monday only had been reinterpreted, preferred to attack this newspaper. Buenos Aires Deputy Health Minister Nicolás Kreplak did so on Twitter (later retweeted by Minister Daniel Gollán) in which he accused Clarín of “disinformation”.

With the newspaper’s coverage on Monday, the official said: “It is really, really painful that the media continues the line of disinformation, transferring fear and uncertainty to all the people, in the midst of a pandemic that already presents these characteristics. ”

The vaccine launch in China faces several challenges, including supply shortages, as acceleration, including on the export front and so-called “vaccine diplomacy,” pushes the ability of domestic manufacturers to the limit.

In addition, uncertainty grows on the protection rate of Chinese vaccines compared to the west of Pfizer and Moderna.

Especially after what Fu said at a press conference in Chendgu on Saturday, in which he said the country is evaluating two ways “to solve the problem” of low efficacy of existing vaccines.

Before Fu returned to his remarks this morning, Liangyou called a timely press conference on Sunday in which he said that the government encourages voluntary vaccination and works to ensure that all those with the right to immunize have access to

“Vaccines not only protect ourselves, but also our loved ones, especially children and the elderly,” said the head of the National Health Commission, who stressed that those over 18, as that participants active in different social contexts, the majority of vaccinated.

China continues to fight against the risk of a return of the epidemic by the number of imported cases, added the epidemiologist, who cited the example of the city of Ruili, in Yunnan province, in the southwest of the country, where new sources of infection were reported at the end of March.